OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization. (April 2018) - Dubrovska, A.; Tyutyunnykova, A.; Chen, O.; Linge, A.; Löck, S.; Telychko, V.; Richter, S.; Hein, L.; Toma, M.; Zschaeck, S.; Eisenhofer, G.; Wirth, M.; et al.